Related Experiment Video

Updated: Jun 12, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.7K

Clinical Implications of Pseudomonas Aeruginosa Colonization in Chronic Obstructive Pulmonary Disease Patients

Wang Chun Kwok1, Terence Chi Chun Tam1, Chi Hung Chau2

  • 1Division of Respiratory Medicine, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.

Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|February 6, 2025
PubMed
Abstract

Insights

Pseudomonas aeruginosa colonization increases the risk of moderate to severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and pneumonia in COPD patients. This finding highlights a potential independent risk factor for these serious respiratory events.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Pseudomonas aeruginosa is a known pathogen in chronic respiratory diseases, with prognostic value in bronchiectasis and cystic fibrosis.
  • Its specific role in chronic obstructive pulmonary disease (COPD) requires further definition.

Purpose of the Study:

  • To investigate the association between Pseudomonas aeruginosa colonization and the risk of acute exacerbations of COPD (AECOPD) in a Chinese population.

Main Methods:

  • A prospective study was conducted in Hong Kong.
  • 327 Chinese patients with COPD were assessed for Pseudomonas aeruginosa colonization.

Main Results:

  • 10.1% of COPD patients were colonized with Pseudomonas aeruginosa.
  • Colonization was associated with significantly increased risks of moderate to severe AECOPD (aOR 3.15), severe AECOPD (aOR 2.59), and pneumonia (aOR 4.19).
  • Patients with colonization experienced a higher annual frequency of moderate to severe AECOPDs (median 1.35 vs 0).

Conclusions:

  • Pseudomonas aeruginosa colonization is a potential independent risk factor for moderate to severe AECOPD and pneumonia in COPD patients without bronchiectasis.
  • This highlights the importance of monitoring and potentially managing Pseudomonas aeruginosa in this patient group.
Keywords:
COPDCOPD exacerbationPseudomonas aeruginosapneumonia

More Related Videos

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

8.4K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.0K

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K